PRKCI promotes immune suppression in ovarian cancer
Sharmistha Sarkar(The University of Texas MD Anderson Cancer Center), Lynda Chin(American Productivity and Quality Center), Ronald A. DePinho(The University of Texas MD Anderson Cancer Center), Christopher A. Bristow(The University of Texas MD Anderson Cancer Center), Michelle S. Hirsch(Perinatal Institute), Sherry Y. Wu(Queensland University of Technology), Ruth Perets(Technion – Israel Institute of Technology), Giulio Draetta(The University of Texas MD Anderson Cancer Center), Michael H. McGuire(Southwestern Medical Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Shruti Malasi(The University of Texas MD Anderson Cancer Center), Prasenjit Dey, Joyce F. Liu(Duke University), Emmet Huang-Hobbs(Memorial Sloan Kettering Cancer Center), Alejandra Ramirez‐Cardenas(Centers for Disease Control and Prevention), Ronny Drapkin(University of Pennsylvania), Kunal Rai(The University of Texas MD Anderson Cancer Center), Qing Chang(Beijing University of Chinese Medicine), Shan Jiang(Inner Mongolia University), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Monika Haemmerle(The University of Texas MD Anderson Cancer Center), Alexei Protopopov
Cited by 100
Related Papers
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k